Table 11.
Probabilistic Model | IPE | Placebo |
---|---|---|
Total QALY for 1 patient, Discounted | ||
Utility Associated with Cardiovascular Health States | 9.88 (0.52) | 9.59 (0.49) |
(SD) | ||
Disutility Associated with Treatment-related AEs (SD) | −0.005 (0.001) | −0.004 (0.001) |
Difference for 1 patient (IPE vs Placebo) | ||
Utility Associated with Cardiovascular Health States | 0.29 | |
Disutility Associated with Treatment-related AEs | −0.001 |
Abbreviations: AE, adverse event; IPE, icosapent ethyl; QALY, quality-adjusted life year; SD, standard deviation.